For Trump, Covid-19 therapeutics are the new vaccines – STAT
Now that it’s clear a vaccine won’t be ready by Election Day, Trump is hyping experimental therapeutics instead.
Now that it’s clear a vaccine won’t be ready by Election Day, Trump is hyping experimental therapeutics instead.
Health economist Ben Handel dissects UnitedHealth CEO Andrew Witty’s Senate testimony on the the Change Healthcare cyberattack.
Novo Nordisk on Thursday defended the prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy amid a Senate probe into what the company…
BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it concentrates its resources on an anticipated launch of its pivotal…
Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these cancer treatments with a new acquisition.
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
CVS Health missed its Q1 projections and lowered its full-year outlook, citing medical cost hikes with Medicare Advantage patients. Its stock price slid.
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
A heart attack or poor circulation from diabetes can wreak damage on blood vessels. Scientists want to use mitochondria to jump-start repairs.
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.